NanoViricides Inc.

AMEX: NNVC · Real-Time Price · USD
1.49
0.02 (1.71%)
At close: Aug 15, 2025, 3:59 PM
1.49
0.00%
After-hours: Aug 15, 2025, 07:35 PM EDT

NanoViricides Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
-9.73M -9.36M -9.45M -8.29M -9.51M -9.36M -8.99M -8.59M -6.8M -6.89M -7.06M -8.11M -8.4M -8.72M -9.12M -8.82M -8.62M -14.6M -14.2M
Depreciation & Amortization
767.08K 772.05K 765.5K 759.01K 757.29K 755.66K 753.25K 747.53K 746.6K 739.84K 730.3K 723.33K 711.53K 706.12K 703.73K 704.54K 703.36K 702.15K 702.07K
Stock-Based Compensation
-84.05K 36.58K 31.94K 43.24K 224.31K 229.84K 233.53K 214.18K 267.47K 291.58K 315.64K 338.42K 327.78K 371.9K 389.14K 405.59K 407.38K 566.06K 561.1K
Other Working Capital
93.83K -182.04K -4.2K 291.06K 1.79M 1.73M 1.9M 1.68M 89.65K 261.92K 151.52K 159.4K 183.89K 189.1K 240.63K 170.64K 230.35K 151.68K 4.54K
Other Non-Cash Items
150.34K 830.43K 1.09M 1.17M 1.14M 494K 229.82K 158K 961.78 1.56K 2.98K 937.59K 938.67K 939.63K 958.37K 33.1K 41.78K 49.85K 174.31K
Deferred Income Tax
n/a n/a -264.25K -336.4K -336.4K -336.4K -72.15K n/a -1.35K -1.35K -1.35K n/a -3.88K -3.88K -634 n/a 8.71K 5.52M 5.66M
Change in Working Capital
635.59K 165.9K 736.52K 996.88K 2.04M 2.09M 2.03M 1.8M 214.02K 368.87K -184.73K 214.56K -300.85K 195.19K 366.07K -540.11K -76.67K -892K -368.65K
Operating Cash Flow
-8.26M -8.21M -7.74M -6.32M -6.33M -6.13M -5.81M -5.67M -5.57M -5.49M -6.2M -5.89M -6.72M -6.5M -6.7M -8.21M -7.54M -8.66M -7.47M
Capital Expenditures
-144.93K -189.56K -195.03K -156.56K -60.96K -75.63K -115.5K -151.71K -224.51K -204.53K -344.54K -324.35K -333.63K -404.86K -228.09K -238.76K -158.62K -48.06K -39.48K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-144.93K -189.56K -195.03K -156.56K -60.96K -75.63K -115.5K -151.71K -224.51K -204.53K -344.54K -324.35K -333.63K -404.86K -228.09K -238.76K -158.62K -48.06K -39.48K
Debt Repayment
n/a n/a n/a n/a n/a n/a -23.84K -94.79K -164.91K -234.2K -234.33K -234.72K -235.1K -235.48K -1.33M -1.3M -1.28M -1.21M 1.01M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.12M 3.12M 3.12M 3.12M n/a n/a n/a n/a 37.41K 37.41K n/a n/a -37.41K -37.41K 41.02K n/a -12.19K 7.55M 7.37M
Financial Cash Flow
7.69M 7.11M 4.83M 3.12M n/a n/a -23.84K -94.79K -127.5K -196.79K -234.33K -234.72K -272.51K 5.85M 4.84M 15.26M 24.49M 26.39M 28.42M
Net Cash Flow
-714.65K -1.29M -3.1M -3.35M -6.39M -6.2M -5.95M -5.92M -5.92M -5.89M -6.78M -6.45M -7.33M -1.06M -2.1M 6.81M 16.79M 17.69M 20.92M
Free Cash Flow
-8.4M -8.4M -7.93M -6.47M -6.39M -6.2M -5.92M -5.82M -5.79M -5.69M -6.54M -6.22M -7.05M -6.91M -6.93M -8.45M -7.7M -8.7M -7.51M